Rosenstock J, Robins DA, Duffin KL, Wilson JM, et al. Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of beta-cell function and insulin sensitivity in type 2 diabetes. Diabetes Obes Metab 2025 Aug 14. doi: 10.1111/dom.70022.
PMID: 40808573